The Impact of Electrocoagulation on Ovarian Reserve After Laparoscopic Excision of Ovarian Cyst

August 15, 2008 updated by: Shandong Provincial Hospital

The Impact of Electrocoagulation on Ovarian Reserve After Laparoscopic Exc

The purpose of this study is to investigate the impact of electrocoagulation on ovarian reserve after laparoscopic excision of ovarian cyst and the possible mechanisms.

Study Overview

Detailed Description

Laparoscopic cystectomy is currently considered the treatment of choice in women with benign ovarian cysts and has gained increasing acceptance among gynecological surgeons(1). However, the safety of this technique in terms of ovarian damage to the operated gonad has recently been questioned. In the present study, with the combined use of serum hormonal evaluation and ultrasound examination, we planned to prospectively investigate the ovarian reserve after the excision of benign ovarian cysts. The damage to ovarian reserve will be evaluated through a 12-months follow-up after the application of bipolar, ultrasonic scalpel electrocoagulation or suture during ovarian cystectomy

Study Type

Interventional

Enrollment (Actual)

192

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Shandong
      • Jinan, Shandong, China, 250021
        • Shandong Provincial Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion criteria:

  • Age 18-40 years
  • Uni/bilateral ovarian cyst(s) without clinical and sonographic suspicion of ovarian cancer
  • Regular menstrual cycles defined as cycle length between 25 and 35 days in the 6 months before surgery
  • Agreement to be enrolled in the study

Exclusion criteria:

  • Prior ovarian surgery
  • Surgical necessity to perform adnexectomy
  • Known endocrine disease
  • Post operative pathologic diagnosis was not benign ovarian cyst
  • Oral contraceptive use before surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: SUPPORTIVE_CARE
  • Allocation: NON_RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: 1
Laparoscopic ovarian cystectomy using bipolar
Laparoscopic ovarian cystectomy using bipolar
Other Names:
  • laparoscopic ovarian cystectomy using bipolar
Laparoscopic ovarian cystectomy using ultrasonic scalpel electrocoagulation
Other Names:
  • laparoscopic ovarian cystectomy using ultrasonic scalpel
Laparotomic ovarian cystectomy using suture
Other Names:
  • Laparotomic ovarian cystectomy using suture
EXPERIMENTAL: 2
Laparoscopic ovarian cystectomy using ultrasonic scalpel
Laparoscopic ovarian cystectomy using bipolar
Other Names:
  • laparoscopic ovarian cystectomy using bipolar
Laparoscopic ovarian cystectomy using ultrasonic scalpel electrocoagulation
Other Names:
  • laparoscopic ovarian cystectomy using ultrasonic scalpel
Laparotomic ovarian cystectomy using suture
Other Names:
  • Laparotomic ovarian cystectomy using suture
ACTIVE_COMPARATOR: 3
Laparotomic ovarian cystectomy using suture
Laparoscopic ovarian cystectomy using bipolar
Other Names:
  • laparoscopic ovarian cystectomy using bipolar
Laparoscopic ovarian cystectomy using ultrasonic scalpel electrocoagulation
Other Names:
  • laparoscopic ovarian cystectomy using ultrasonic scalpel
Laparotomic ovarian cystectomy using suture
Other Names:
  • Laparotomic ovarian cystectomy using suture

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Serum FSH and E2 assays
Time Frame: 12 months
12 months

Secondary Outcome Measures

Outcome Measure
Time Frame
Transvaginal ultrasound examinations for basal antral follicle number, mean ovarian diameter and peak systolic velocity
Time Frame: 12 months
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Study Director: changzhong li, M.D., Shandong Provincial Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2003

Primary Completion (ACTUAL)

May 1, 2008

Study Completion (ACTUAL)

May 1, 2008

Study Registration Dates

First Submitted

July 7, 2008

First Submitted That Met QC Criteria

July 7, 2008

First Posted (ESTIMATE)

July 11, 2008

Study Record Updates

Last Update Posted (ESTIMATE)

August 18, 2008

Last Update Submitted That Met QC Criteria

August 15, 2008

Last Verified

July 1, 2008

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ovarian Cysts

Clinical Trials on Ovarian cystectomy

3
Subscribe